| human | Q5 |
| P10058 | IRIS UNIBO author ID | 23035 |
| P2798 | Loop ID | 126712 |
| P3835 | Mendeley person ID | michele-mishto |
| P856 | official website | https://kclpure.kcl.ac.uk/portal/en/persons/michele-mishto(a06498df-98e9-413b-8bfc-46549dee43f5).html |
| P496 | ORCID iD | 0000-0003-3042-2792 |
| P3829 | Publons author ID | 1473831 |
| P1053 | ResearcherID | A-5592-2010 |
| P1153 | Scopus author ID | 6507657314 |
| P69 | educated at | University of Bologna | Q131262 |
| P108 | employer | Charité | Q162684 |
| King's College London | Q245247 | ||
| Francis Crick Institute | Q326044 | ||
| University of Eastern Piedmont | Q1235561 | ||
| P735 | given name | Michele | Q18620536 |
| Michele | Q18620536 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q38730967 | A large fraction of HLA class I ligands are proteasome-generated spliced peptides. |
| Q40324090 | A mathematical model of protein degradation by the proteasome |
| Q48588098 | A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms |
| Q43842952 | Age dependent impact of LMP polymorphisms on TNFalpha-induced apoptosis in human peripheral blood mononuclear cells |
| Q47171599 | An Unexpected Major Role for Proteasome-Catalyzed Peptide Splicing in Generation of T Cell Epitopes: Is There Relevance for Vaccine Development? |
| Q91707889 | An in silico-in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients |
| Q46603274 | Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. |
| Q56976335 | Author Correction: NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity |
| Q40779616 | CD8(+) T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products |
| Q37541906 | Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis |
| Q34347732 | Driving forces of proteasome-catalyzed peptide splicing in yeast and humans |
| Q91293224 | ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope |
| Q43188727 | Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study |
| Q21136190 | Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease |
| Q37690125 | Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis |
| Q36647435 | Genes, ageing and longevity in humans: problems, advantages and perspectives. |
| Q112305578 | Identification of a class of non-conventional ER-stress-response-derived immunogenic peptides |
| Q33533349 | Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population |
| Q46812261 | Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains |
| Q52896649 | Immunoproteasome expression is induced in mesial temporal lobe epilepsy. |
| Q46912393 | Immunoproteasome in Macaca fascicularis: no age-dependent modification of abundance and activity in the brain and insight into an in silico structural model |
| Q38047009 | Immunoproteasome in cancer and neuropathologies: a new therapeutic target? |
| Q35548615 | Immunoproteasomes and immunosenescence |
| Q94948572 | Large database for the analysis and prediction of spliced and non-spliced peptide generation by proteasomes |
| Q35284362 | Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver |
| Q93051764 | Mapping the MHC Class I-Spliced Immunopeptidome of Cancer Cells |
| Q43966210 | Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kinetics |
| Q33912642 | Modelling proteasome and proteasome regulator activities. |
| Q37470941 | Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities |
| Q40109795 | Multi-level Strategy for Identifying Proteasome-Catalyzed Spliced Epitopes Targeted by CD8+ T Cells during Bacterial Infection |
| Q55109506 | NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity. |
| Q24628450 | Network, degeneracy and bow tie. Integrating paradigms and architectures to grasp the complexity of the immune system |
| Q38662997 | Neuroinflammatory targets and treatments for epilepsy validated in experimental models. |
| Q34718525 | Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brain |
| Q40083920 | Post-Translational Peptide Splicing and T Cell Responses |
| Q55109543 | Proteasome Modulation in Brain: A New Target for Anti-Aging Drugs? |
| Q38955527 | Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation |
| Q36769053 | Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes |
| Q92635576 | Proteolytic dynamics of human 20S thymoproteasome |
| Q36177598 | Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes |
| Q40552360 | Strategies to enhance immunogenicity of cDNA vaccine encoded antigens by modulation of antigen processing |
| Q43050878 | Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis |
| Q37730157 | Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies. |
| Q33627497 | The 20S proteasome splicing activity discovered by SpliceMet |
| Q36381923 | The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing |
| Q44886980 | The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. |
| Q48144612 | The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy. |
| Q37705431 | Towards a liquid self: how time, geography, and life experiences reshape the biological identity |
| Q64069427 | Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis |
| Q63987412 | Why do proteases mess up with antigen presentation by re-shuffling antigen sequences? |
| Q115039693 | inSPIRE: An open-source tool for increased mass spectrometry identification rates using Prosit spectral prediction |
| Q44234398 | p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes |
Search more.